Peter D Reaven
Overview
Explore the profile of Peter D Reaven including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
106
Citations
4952
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Koska J, Nuyujukian D, Bahn G, Zhou J, Reaven P
Cardiovasc Diabetol
. 2021 Dec;
20(1):232.
PMID: 34879878
Aims: Low C-peptide levels, indicating beta-cell dysfunction, are associated with increased within-day glucose variation and hypoglycemia. In advanced type 2 diabetes, severe hypoglycemia and increased glucose variation predict cardiovascular (CVD)...
22.
Abbasi F, Lamendola C, Harris C, Harris V, Tsai M, Tripathi P, et al.
Arterioscler Thromb Vasc Biol
. 2021 Aug;
41(11):2786-2797.
PMID: 34433298
Objective: Statin treatment reduces the risk of atherosclerotic cardiovascular disease but is associated with a modest increased risk of type 2 diabetes, especially in those with insulin resistance or prediabetes....
23.
Nuyujukian D, Zhou J, Koska J, Reaven P
J Hypertens
. 2021 Jul;
39(11):2173-2182.
PMID: 34232160
Objectives: As there is uncertainty about the extent to which baseline blood pressure level or cardiovascular risk modifies the relationship between blood pressure variability (BPv) and cardiovascular disease, we comprehensively...
24.
Azad N, Agrawal L, Bahn G, Emanuele N, Reaven P, Hayward R, et al.
Diabetes Care
. 2021 Jun;
PMID: 34187839
Objective: The objective of this study was to assess the long-term role of intensive glycemic control (INT) compared with standard glycemic control in accumulated eye procedures in patients with advanced...
25.
Zhou J, Nuyujukian D, Reaven P
Curr Cardiol Rep
. 2021 Mar;
23(4):25.
PMID: 33655430
Purpose Of Review: There is evidence from epidemiologic studies that variability in cardiovascular risk factors influences risk of cardiovascular disease. We review new studies and novel findings in the relationship...
26.
Koska J, Migrino R, Chan K, Cooper-Cox K, Reaven P
Diabetes Care
. 2021 Jan;
44(6):1385-1392.
PMID: 33495294
Objective: Glucagon-like peptide 1 receptor agonists (GLP-1RAs) improved multiple proatherogenic risk factors and reduced cardiovascular events in recent clinical trials, suggesting that they may slow progression of atherosclerosis. We tested...
27.
Serper M, Vujkovic M, Kaplan D, Carr R, Lee K, Shao Q, et al.
PLoS One
. 2020 Aug;
15(8):e0237430.
PMID: 32841307
Background & Aims: Given ongoing challenges in non-invasive non-alcoholic liver disease (NAFLD) diagnosis, we sought to validate an ALT-based NAFLD phenotype using measures readily available in electronic health records (EHRs)...
28.
Vujkovic M, Keaton J, Lynch J, Miller D, Zhou J, Tcheandjieu C, et al.
Nat Genet
. 2020 Jun;
52(7):680-691.
PMID: 32541925
We investigated type 2 diabetes (T2D) genetic susceptibility via multi-ancestry meta-analysis of 228,499 cases and 1,178,783 controls in the Million Veteran Program (MVP), DIAMANTE, Biobank Japan and other studies. We...
29.
Nuyujukian D, Koska J, Bahn G, Reaven P, Zhou J
Diabetes Care
. 2020 Apr;
43(7):1471-1478.
PMID: 32327422
Objective: Although blood pressure variability is increasingly appreciated as a risk factor for cardiovascular disease, its relationship with heart failure (HF) is less clear. We examined the relationship between blood...
30.
Sheng C, Tian J, Miao Y, Cheng Y, Yang Y, Reaven P, et al.
Diabetes Care
. 2020 Apr;
43(6):1185-1190.
PMID: 32229597
Objective: The association between high glycemic variability and all-cause mortality has been widely investigated in epidemiological studies but rarely validated in glucose-lowering clinical trials. We aimed to identify the prognostic...